|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||82.65 - 83.15|
|52 Week Range||66.93 - 86.90|
|PE Ratio (TTM)||31.11|
|Dividend & Yield||2.72 (3.28%)|
|1y Target Est||N/A|
The first new malaria drug to emerge for 20 years is beginning clinical trials in nine countries across Africa and Asia. KAF156 could be "a game changer", its developers say, at a time when the ...
The therapy, Besponsa, treats a rapidly progressing version of the disease.
House Democrats start probe into MS drug prices